Cullinan Therapeutics, Inc. (CGEM)
NASDAQ·Healthcare·Medical - Pharmaceuticals
$14.57
+7.45%
Mkt Cap $841.98M
Analyst Ratings
Buy
9
Hold
0
Sell
0
Price Target (16 analysts)
$31.29
Range $26.00 – $38.00
Implied Upside
+114.8%
Consensus $31.29 vs current $14.57